Lincomycin API Manufacturers

Looking for Lincomycin API 154-21-2?

Description:

Here you will find a list of producers, manufacturers and traders of Lincomycin. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Lincomycin 

Synonyms:

LCM , Lincomycine , Lincomycin hydrochloride  

Cas Number:

154-21-2 

DrugBank number:

DB01627 

Unique Ingredient Identifier:

BOD072YW0F

Lincomycin is a type of Lincosamide

Lincosamides are a vital subcategory of pharmaceutical Active Pharmaceutical Ingredients (APIs) widely used in the field of medicine. These antibiotics, including the well-known compound clindamycin, exhibit potent antibacterial properties against Gram-positive bacteria.

Lincosamides function by inhibiting bacterial protein synthesis, specifically targeting the 50S subunit of the bacterial ribosome. By binding to this subunit, lincosamides impede the synthesis of essential bacterial proteins, preventing bacterial growth and replication.

One notable characteristic of lincosamides is their ability to penetrate various body tissues effectively, making them suitable for treating both systemic and localized infections. They are particularly effective against infections caused by Streptococcus, Staphylococcus, and anaerobic bacteria.

Clindamycin, the most commonly used lincosamide, is available in various formulations, including oral capsules, injections, and topical creams. This versatility allows healthcare professionals to administer the medication through the most appropriate route based on the infection's severity and location.

Like other pharmaceutical APIs, lincosamides undergo rigorous quality control measures to ensure their safety, efficacy, and compliance with regulatory standards. The production of lincosamide APIs adheres to Good Manufacturing Practices (GMP) guidelines to maintain consistent quality and purity.

In conclusion, lincosamides are a crucial class of antibiotics that inhibit bacterial protein synthesis, demonstrating significant effectiveness against Gram-positive bacteria. With their diverse formulations and reliable quality control, lincosamide APIs play a vital role in combating various bacterial infections, enhancing patient outcomes, and promoting public health.

Lincomycin (Lincosamide), classified under Anti-infective Agents

Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.

• AMARI TRADE ALLIANEC LLP from India
• Shandong Octagon Chemicals Limited from China
• Otto Brandes GmbH from Germany
• Livzon Group from China
• Shandong Fangming from China
• Jiangsu Hibroad BP from China
• Topfond Pharma from China
• Suzhou No.4 from China
• North China Pharma Group Aino from China
• HEC Pharm from Germany
• Ningxia Taiyicin Biotech from China
• Jiangxi Guoyao from China
• Pharmacia & Upjohn from United States
• Xinyu Pharma from China
• Shaoxing Hantai Pharma from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.